Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Do sugar-sweetened beverages cause adverse health outcomes in adults? A systematic review protocol
2014
A systematic review and meta-analysis on the prevalence of Escherichia coli and extended-spectrum β-lactamase-producing Escherichia coli in pregnant women
2021
Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments
2014 Standout
A protocol for a systematic review for perioperative pregabalin use
2012
The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS)
2008
Depression
2018 Standout
Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
2017
A systematic review of the content of critical appraisal tools
2004
Engineering precision nanoparticles for drug delivery
2020 Standout
Automatic classification of MR scans in Alzheimer's disease
2008 Standout
Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties
2014
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Structural racism and health inequities in the USA: evidence and interventions
2017 Standout
Reports of Large Immunosuppression Trials in Kidney Transplantation: Room for Improvement
2004
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
2018 Standout
Cardio-Pulmonary-Renal Interactions
2015
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
2014 Standout
Alzheimer's disease
2011 Standout
Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion
2009
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
2012 Standout
Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study
2010
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Racism as a Determinant of Health: A Systematic Review and Meta-Analysis
2015 Standout
Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: Exploring the influence of various parameters
2010 Standout
EFNS guidelines for the diagnosis and management of Alzheimer’s disease
2010
Economic Evaluation of Treatment Options in Patients with Alzheimerʼs Disease
2012
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Acute kidney injury
2019 Standout
Clinical Global Impression of Change in Physical Frailty: Development of a Measure Based on Clinical Judgment
2004
Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology
2005
Resuming the discussion of AMSTAR: What can (should) be made better?
2016
Neighborhood socioeconomic status and child sleep duration: A systematic review and meta-analysis
2020
Photochemical synthesis of substituted indan-1-ones related to donepezil
2008
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Clinical trials of new drugs for Alzheimer disease
2020
Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men
2005
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
2015
Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2
2011
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
2013
Alzheimer's disease: Targeting the Cholinergic System
2016
The effects of excluding treatments from network meta-analyses: survey
2013
Effective Exercise for the Prevention of Falls: A Systematic Review and Meta‐Analysis
2008 Standout
Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies
2007
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
2009
Type 2 diabetes mellitus
2015 Standout
Scoping reviews: time for clarity in definition, methods, and reporting
2014 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Update on the Pharmacological Treatment of Alzheimers Disease
2010
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Effects of Ginkgo biloba in dementia: systematic review and meta-analysis
2010
Prediabetes: a high-risk state for diabetes development
2012 Standout
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
A global clinical measure of fitness and frailty in elderly people
2005 Standout
Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure
2017
GluN2B subunit-containing NMDA receptor antagonists prevent Aβ-mediated synaptic plasticity disruption in vivo
2009
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Reliability of the PEDro Scale for Rating Quality of Randomized Controlled Trials
2003 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies
2015
Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
2012 Standout
A microfluidic platform with digital readout and ultra-low detection limit for quantitative point-of-care diagnostics
2015
Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force
2016
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
2018
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
The Treatment of Alzheimer Disease
2008
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes
2015
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
The art and science of knowledge synthesis
2010
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Review Article: Genetics of Alzheimer Disease
2010
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Disease-modifying treatments for Alzheimer’s disease
2011
Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physicians.
2014
Treatment of Anemia in Patients With Heart Disease
2013
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Mark Oremus being referenced
Selecting Observational Studies for Comparing Medical Interventions
2008
Inter-rater and test–retest reliability of quality assessments by novice student raters using the Jadad and Newcastle–Ottawa Scales
2012
No clear choice between Newcastle–Ottawa Scale and Appraisal Tool for Cross-Sectional Studies to assess methodological quality in cross-sectional studies of health-related quality of life and breast cancer
2019
Review of Outcome Measurement Instruments in Alzheimer's Disease Drug Trials: Introduction
2000
Observational studies in systemic reviews of comparative effectiveness: AHRQ and the Effective Health Care Program
2011
Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program
2011
A Systematic Review to Assess the Policy-Making Relevance of Dementia Cost-of-Illness Studies in the US and Canada
2010
Review of Outcome Measurement Instruments in Alzheimer's Disease Drug Trials: Psychometric Properties of Behavior and Mood Scales
2000
A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods
2014
Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence
2014
Review of Outcome Measurement Instruments in Alzheimer's Disease Drug Trials: Psychometric Properties of Functional and Quality of Life Scales
2000
Physicians' Efficacy Requirements for Prescribing Medications to Persons with Alzheimer's Disease
2007
A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease
2007
Incremental value of natriuretic peptide measurement in acute decompensated heart failure (ADHF): a systematic review
2014
Systematic review of economic evaluations of Alzheimer’s disease medications
2008
BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review
2014
Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness
2002
Interrater Reliability of the Modified Jadad Quality Scale for Systematic Reviews of Alzheimer’s Disease Drug Trials
2001
Review of Outcome Measurement Instruments in Alzheimer's Disease Drug Trials: Psychometric Properties of Global Scales
2000
Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review
2014
Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.
2006
Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
2008